Contingency Management to Promote Smoking Abstinence in Cancer Patients
Overview
- Phase
- Not Applicable
- Intervention
- Contingency Management
- Conditions
- Smoking Cessation
- Sponsor
- Medical University of South Carolina
- Enrollment
- 282
- Locations
- 1
- Primary Endpoint
- Abstinence Rates as assessed by self-report for past 7 days, Carbon Monoxide Breath Monitoring and/or Anabasine testing
- Status
- Completed
- Last Updated
- last month
Overview
Brief Summary
This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 or older
- •smoking 1 or more combustible tobacco products per day
- •diagnosed with or suspicion of any type of operable cancer
Exclusion Criteria
- •unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia
- •non-English speaking
- •use of alternative nicotine delivery systems (e.g., e-cigarettes, snus, etc)
- •pregnant women
Arms & Interventions
Contingency Management
Intervention: Contingency Management
Standard Care
Intervention: Standard Care
Outcomes
Primary Outcomes
Abstinence Rates as assessed by self-report for past 7 days, Carbon Monoxide Breath Monitoring and/or Anabasine testing
Time Frame: Changes between the study intake appointment to day of surgery, up to five weeks apart
Abstinence will be defined by 7 days by self-report of no tobacco products, confirmed by CO breath test less than or equal to 4ppm and/or urine anabasine levels less than or equal to 2 ng/ml
Secondary Outcomes
- Abstinence Rates as assessed by self-report for past 7 days, Carbon Monoxide Breath Monitoring and/or Anabasine testing(Three and Six months after surgery date)